Ad hoc Press Release

Ad hoc Press Release According to § 15 WphG

MediGene AG Decides on a Revision of the Development Plans for EndoTAGTM-1 and RhuDexTM, and Downsizes its Executive Board  2009-12-11 MediGene receives Positive Decisions on Market Approval for Veregen® in First European Countries   2009-07-10 MediGene AG Appoints Dr. Frank Mathias as new Chief Executive Officer   2009-04-29 MediGene to be Listed on TecDAX Index  2009-02-05

For further information please contact Julia Hofmann or Georg Dönges, Public Relations, MediGene AG Contact